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Mainly in individuals with immunologic defects or trauma, Prototheca spp. can cause even le-
thal diseases. However, the exact pathogenic mechanism of Prototheca in causing disease re-
mains largely unknown. To investigate the differences between pathogenic and nonpathogenic
Prototheca spp. genotypes on proteome level, a nonpathogenic Prototheca zopfii genotype 1
strain, isolated from cow manure, and a human pathogenic P. zopfii genotype 2, isolated from
human granulomatous lymphadenitis, were studied.
Methods: Differentially expressed proteins between the two genotypes were quantified by
isobaric tag for relative and absolute quantitation-based quantitative proteomics, using liquid
chromatographyetandem mass spectrometry.
Results: A total of 245 proteins were identified from the proteomic analysis after data filtering
to eliminate low-scoring spectra. Among these, 35 proteins that displayed a significant
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the genotype 2 strain, and are thus potentially relevant in the pathogenic mechanism of P. zop-
fii genotype 2, but need further investigation.
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Prototheca species are ubiquitous, unicellular, achlor-
ophyllic microalgae belonging to the family Chlorellaceae,
which can cause a wide range of infections in humans and
animals.1e3 Mainly in individuals with immunologic defects
or trauma, Prototheca spp. can gain access into the body,
and cause even lethal disease.4e6 The first case of human
protothecosis was described by Davies and colleagues in
19647 and, since then, over 160 cases have now been re-
ported in literature, with approximately one-third of cases
reported in the past 5 years.5 By contrast, because of their
yeast-like appearance when cultured on Sabouraud
dextrose agar and their staining patterns, they were
considered to be fungal-like organisms.8 Trends over time
demonstrate that reports of protothecosis have become
more common as corticosteroid use has become more
frequent and the pool of surviving immune-compromised
patients has increased.5 However, the exact role of these
organisms as pathogens in human infections remains largely
unknown.2,3
The taxonomic status of Prototheca has evolved over
several decades, and six species are currently assigned to
the genus Prototheca: Prototheca zopfii, Prototheca stag-
nora, Prototheca wickerhamii, Prototheca ulmea, Proto-
theca blaschkeae, and Prototheca cutis sp. nov.9 Among
them, P. zopfii and P. wickerhamii have been associated
with human diseases.10 Based on biochemical, serological,
and genetic analyses, P. zopfii has been classified into two
genotypes, 1 and 2.3 Interestingly, it is genotype 2 that has
been associated with animal and human diseases, while
genotype 1 is nonpathogenic.3,11 The exact mechanism of P.
zopfii genotype 2 infection remains unknown.3
To investigate possible differences between the patho-
genic and nonpathogenic P. zopfii genotypes on the prote-
ome level, P. zopfii genotype 1 strain, isolated from cow
manure, and pathogenic P. zopfii genotype 2, isolated from
human granulomatous lymphadenitis, were chosen for the
study. Further detailed information on these two strains can
be found respectively in Kano et al12 and our earlier study.13Methods
Strain cultivation conditions and proteome
extraction
Each strain was cultured in Sabouraud dextrose liquid me-
dium at 37C until the OD600 reached 0.6 (mid-logarithmic
growth phase), and the experimental design included twou Yuan-zhi, et al., Isobaric tag fo
heca zopfii genotype 2 and enviro
rg/10.1016/j.jmii.2016.07.003biological replicates of each strain. The cells were
collected after centrifugation, and washed twice with
phosphate-buffered saline. According to the mass ratio of
1:5, the cells were resuspended in 1000 mL lysis solution (8M
urea, 0.1% phenylmethylsulfonyl fluoride, 2% CHAPS, 65mM
dithiothreitol), and then ultrasound was conducted at
150 W, with 120 periods of 2 seconds and 13 seconds on ice.
The lysate was centrifuged at 20800 g for 30 minutes at 4C,
and supernatant was collected. An aliquot (3 mL) of super-
natant from each lysate was used for protein quantification
using the 2-D Quant Kit assay reagents (Amersham, GE
Healthcare, Piscataway, NJ, USA) according to the manu-
facturer’s instructions. Finally, a standard curve was
generated by plotting the absorbance of the standards
against the quantity of protein, and this was used to
determine the protein concentration of the samples. The
samples were then lyophilized and stored at e80C.
Protein digestion and isobaric tag for relative and
absolute quantitation labeling
The digestion and isobaric tag for relative and absolute
quantitation (iTRAQ) labeling of proteins from the four
samples (100 mg each) was performed using iTRAQ Reagent
8-plex Kit (Applied Biosystems, Foster City, CA, USA) ac-
cording to the manufacturer’s protocol. For digestion, the
labeled protein samples from the previous step were re-
dissolved in 2 mL reducing reagent and vortexed at 60C for
1 hour to break up the disulfide bonds. After this, 1 mL
cysteine blocking reagent was added and the contents
centrifuged and then spun at room temperature for 30
minutes. An aliquot (35 mL) from each sample was then
digested with sequencing grade modified trypsin solution
(1:50 w/w added) for 16 hours at 37C. The aliquots with
the digested sample were brought to room temperature
after addition of 70 mL of ethanol to each reagent vial. Each
of these vials was then appropriately labeled with the
iTRAQ tags as follows: two replica clinical isolates of P.
zopfii (115 and 116 iTRAQ tags) and environmental isolates
of P. zopfii (119 and 121 iTRAQ tags). Each tube was vor-
texed and then incubated at room temperature for 1 hour.
The labeled samples were combined and dried by vacuum
centrifuging.
Two-dimensional nano-liquid chromatography
tandem mass spectrometry analysis
After desalting with Sep-Pak Vac C18 cartridge (Waters,
Milford, MA, USA), the labeled sample was fractionated byr relative and absolute quantitation-based comparative proteomic
nmental genotype 1 strains, Journal of Microbiology, Immunology
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madzu, Kyoto, Japan) connected to a high pH reverse phase
column (XBridge BEH130 C18, 2.1 mm 100 mm, 3.5 mm,
200 A˚; Waters). High pH reverse phase separation was per-
formed using a linear binary gradient of 0e45% buffer B
(10mM ammonium acetate in 95% acetonitrile, pH 10) in
buffer A (10mM ammonium acetate in 5% acetonitrile, pH 10)
at a flow rate of 200 mL/min for 25 minutes, and 30 fractions
were collected every 0.5 minutes. Each fraction was dried
down by the rotary vacuum concentrator, dissolved in buffer
C (5% acetonitrile, 0.1% formic acid) and analyzed on a 4600
system (Applied Biosystems) interfaced with a 20AD high-
performance LC system (Shimadzu). Peptides were sepa-
rated on a Zorbax 300SB-C18 column (Agilent Technologies,
Santa Clara, CA, USA). The high-performance LC gradient
was 5e35% buffer B (95% acetonitrile, 0.1% formic acid) in
buffer A (5% ACN, 0.1% formic acid) at a flow rate of 0.3 mL/
min in 90 minutes. Survey scans were acquired fromm/z 400
to m/z 1800 with up to 15 precursors selected for tandem
mass spectrometry (MS/MS from m/z 100 to m/z 2000 with
dynamic exclusion time of 25 seconds. Data acquisition and
processing was conducted by the Analyst Software (Applied
Biosystems), which is a flexible data system that provides
instrument control and data analysis for the entire family of
Applied Biosystems mass spectrometers and related in-
struments. The identification and quantification of the pro-
teins was performed by the ProteinPilot Software (Applied
Biosystems). Each MS/MS was searched in the Uniprot data-
base under the Chlorellaceae family of algae, to which
Prototheca belong.
Bioinformatics analysis and interpretation
Proteins displaying a 1.5-fold change between the clinical
and environmental strains of P. zopfii were considered as
differentially expressed proteins if t test p< 0.05. Two
biological replicates of each of the two strains were used
for analyzing differentially expressed proteins between the
two different pathogenic strains of Prototheca (clinical
isolates of P. zopfii A1 and A2 vs. environmental isolates of
P. zopfii B1 and B2). Cluster of orthologous groups of pro-
teins (COG) and Kyoto Encyclopedia of Genes and Genomes
(KEGG) Pathway analyses (http://www.genome.jp/kegg/
pathway.html) were conducted. Gene ontology (GO) func-
tional analysis was performed using the BLAST2GO software
(BioBam Bioinformatics S.L., Valencia, Spain).
Results
Overview of the quantitative proteomics analysis
A total of 245 proteins were identified from the iTRAQ-LC-
MS/MS proteomic analysis after data filtering to eliminate
low-scoring spectra. Among these, 35 proteins displayed a
significant (p< 0.05) 1.5-fold change between the two
different P. zopfii genotype strains studied, and were thus
considered as differentially expressed proteins. Further-
more, among the 35 differentially expressed proteins, 22
proteins were clearly identified, including name, function
annotation, and coding DNA sequences, whilst the
remaining 13 were putative uncharacterized proteinsPlease cite this article in press as: Liu Yuan-zhi, et al., Isobaric tag for
analysis of human pathogenic Prototheca zopfii genotype 2 and enviro
and Infection (2016), http://dx.doi.org/10.1016/j.jmii.2016.07.003(Table 1). Considering that limited research data are
available on the pathogenicity of Prototheca, and that
many proteins in the Prototheca genome are still annotated
as hypothetical proteins, the relatively high percentage of
functionally unknown proteins identified in the present
study is reasonable. A total of 16 proteins were upregu-
lated, including CTP synthase, histone H4, and 40S ribo-
somal protein S18, S6, S5 as well as S23-2, while 19
proteins, including plasma membrane ATPase, aconitate
hydratase, and malate dehydrogenase, were down-
regulated for the clinical strains.
COG analysis
The COGNITOR program was utilized to achieve the func-
tional annotation of the identified proteins in terms of COG.
The largest proportion (15%) of the differentially expressed
proteins was associated with translation, ribosomal struc-
ture, and biogenesis, followed by 11% proteins related to
energy production and conversion, and 8% responsible for
carbohydrate transport and metabolism (Figure 1).
Furthermore, according to the functional classification of
the differentially expressed proteins in the COG mapping
(Table 2), six out of seven proteins in the functional clas-
sification of translation, ribosomal structure, and biogen-
esis, were upregulated for the clinical isolates, while all
seven proteins in the classifications of energy production
and conversion, and carbohydrate transport and meta-
bolism, were downregulated. These findings suggest sup-
pressed energy production and carbohydrate metabolism,
and enhanced translation, ribosomal structure, and
biogenesis, as adaptation to an infectious life cycle for
clinical P. zopfii.
GO of identified proteins
The GO Consortium databases were used to categorize the
identified proteins according to cellular component, mo-
lecular function, and biological process.3 Under the bio-
logical process category, 28% and 25% proteins were related
to cellular process and metabolic process respectively
(Figure 2A). The molecular function cluster mostly dis-
played the binding and catalytic activity function
(Figure 2B). By contrast, the cellular component showed
that 30% was cell part, organelle part (19%), membrane-
bound organelle (18%), and nonmembrane-bound organ-
elle part (15%) (Figure 2C).
KEGG pathway analysis
In the KEGG pathway analysis, the previously mentioned
downregulated proteins for pathogenic P. zopfii genotype
isolates were also described. The citrate cycle and oxida-
tive phosphorylation pathways are related to the reduced
key enzymes reductase (Hþ-translocating) and dehydroge-
nase (Figure 3A), which are consistent with most of the
downregulated proteins including ATPase, aconitate
hydratase, and NADH dehydrogenase ironesulfur protein 8-
A. In addition, the external acidification in plants and the
internal alkalization in fungi, both resulting from activation
of the Hþ pump, have been proposed to mediate growthrelative and absolute quantitation-based comparative proteomic
nmental genotype 1 strains, Journal of Microbiology, Immunology
Table 1 List of differential expressed proteins identified by isobaric tag for relative and absolute quantitation.
Unuseda %Covb Accession Protein name Gene name Peptides
(95%)
Clinical isolates
of Prototheca
zopfii
Environmental
isolates of
P .zopfii
Sigc
14.98 30.33 A0A087SDZ5 Plasma membrane ATPase F751_6917 14 0.29 0.82 1
13.63 43.72 A0A087SS91 Aconitate hydratase, mitochondrial F751_6354 14 0.52 2.45 1
11.66 36.18 A0A087SC94 Malate dehydrogenase, glyoxysomal F751_1044 13 1.39 2.72 1
6.43 35.25 E1ZRV3 Putative uncharacterized protein CHLNCDRAFT_59237 6 0.84 6.54 1
6.35 35.69 E1ZCI5 Putative uncharacterized protein CHLNCDRAFT_51922 6 0.44 1.54 1
5.59 28.16 A0A087ST52 CTP synthase F751_4070 3 0.92 0.60 1
4.88 34.87 E1Z5J4 Cytoplasmic ribosomal protein S13 CHLNCDRAFT_55999 3 1.28 0.35 1
4.1 22.12 A0A087SKC3 Phosphoglucomutase, chloroplastic F751_4670 5 0.74 1.13 1
4.01 55.34 E1ZFV0 Histone H4 CHLNCDRAFT_134363 4 1.05 0.47 1
4 66.01 A0A087SIA2 40S ribosomal protein S18 F751_0483 2 1.11 0.26 1
4 25.91 E1ZDD4 40S ribosomal protein S6 CHLNCDRAFT_59656 4 1.07 0.52 1
4 33.33 A0A087SIB1 NADH dehydrogenase [ubiquinone]
ironesulfur protein 8-A, mitochondrial
F751_0492 3 0.39 1.69 1
4 32.47 E1ZQY4 40S ribosomal protein S5 CHLNCDRAFT_37294 6 1.00 0.58 1
2.48 44.89 E1ZDX3 Putative uncharacterized protein CHLNCDRAFT_145205 2 0.41 0.65 1
2.44 16.58 A0A087SKD7 ATP-binding cassette sub-family B member 9 F751_4684 1 0.92 1.43 1
2.01 26.77 E1ZNH9 Putative uncharacterized protein CHLNCDRAFT_36776 1 1.44 0.28 1
2 46.13 A0A087SK35 Prohibitin-1 F751_6240 1 0.95 1.47 1
2 38.52 A0A087SC60 Adenylate kinase B F751_1010 2 0.74 1.71 1
2 80.3 E1ZQ26 Putative uncharacterized protein CHLNCDRAFT_27155 5 1.02 3.93 1
2 10.37 A0A087S9N3 40S ribosomal protein S23-2 F751_0120 2 1.16 0.51 1
1.15 21.66 E1ZTW0 Putative uncharacterized protein CHLNCDRAFT_37706 1 1.04 0.24 1
0.63 39.67 E1Z835 Putative uncharacterized protein CHLNCDRAFT_20219 1 0.99 1.95 1
0.57 31.45 A0A087SHT7 Methylmalonate semialdehyde
dehydrogenase (acylating), mitochondrial
F751_3971 1 1.18 4.70 1
0.52 51.37 E1ZQV5 Putative uncharacterized protein CHLNCDRAFT_32922 1 1.91 0.15 1
0.47 42.51 E1ZMJ3 Putative uncharacterized protein CHLNCDRAFT_54108 0 0.81 1.42 1
0.35 33 A0A087SDQ9 Breast cancer type 2 susceptibility
protein-like protein
F751_6831 0 1.23 0.35 1
0.31 20 E1Z5M5 Putative uncharacterized protein CHLNCDRAFT_59578 1 0.84 0.52 1
0.21 18.8 A0A087SCD4 REVERSED GDP-mannose 3,5-epimerase 2 F751_1084 0 9.58 27.06 1
0.17 20.86 A0A087SGS4 Succinyl-CoA:3-ketoacid-coenzyme A transferase F751_1807 0 5.40 1.89 1
0.11 20.75 A0A087SLE2 Uncharacterized protein F751_2133 0 1.66 3.01 1
0.08 19.28 E1ZHR5 Putative uncharacterized protein CHLNCDRAFT_135218 0 0.78 0.45 1
0.08 19.91 A0A087SE71 Elongation factor Tu F751_0209 0 0.81 1.50 1
0.06 18.87 E1Z494 Formin-like protein CHLNCDRAFT_137684 0 0.50 1.03 1
0.06 12.06 E1ZK64 Putative uncharacterized protein CHLNCDRAFT_53533 0 0.97 0.50 1
0.05 38.18 A0A087SN17 DEAD-box ATP-dependent RNA helicase 36 F751_1294 0 2.10 0.80 1
a Unused protein score.
b The percentage of the protein sequence covered by peptides identified using quantitative mass spectrometry.
c 1 or e1 was considered statistically significant. 1 indicates downregulated for the clinical strains, and e1 indicates upregulated for the
clinical strains.
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Figure 1. Cluster of orthologous groups distribution of identified proteins.
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+ MODELresponses.14 Therefore, some key enzymes such as ATPase
can be considered as potential virulence proteins. Besides,
the KEGG pathway analysis revealed that biosynthesis of
antibiotics was the most important pathway, including key
enzymes such as phosphohexokinase, hydratase, kinase,
and dehydrogenase, while the other activities were evenly
distributed (Figure 3B).Discussion
The pathogenesis and virulence factors of P. zopfii remain
unknown. In this study, we used iTRAQ strategy for the first
time, to comprehensively evaluate differentially expressed
proteins of two P. zopfii genotype isolates, one pathogenic
and the other not.
Among the differentially expressed proteins, cyto-
plasmic ribosomal protein S13, 40S ribosomal proteins S18,
S6, S5, and S23-2, were all upregulated, which in the Uni-
prot database, are consistently annotated as structural
constituents of ribosome and translation. It is known that
the expression of ribosomal protein genes in eukaryotes can
be regulated at the levels of transcription,15 translation,16
and splicing.17,18 Ribosomal protein S13 has been shown
to inhibit excision of intron 1 from rpS13 pre-mRNA frag-
ment in vitro and to specifically bind the fragment,Please cite this article in press as: Liu Yuan-zhi, et al., Isobaric tag for
analysis of human pathogenic Prototheca zopfii genotype 2 and enviro
and Infection (2016), http://dx.doi.org/10.1016/j.jmii.2016.07.003including conferring protection against ribonuclease
cleavage at sequences near the 50 and 30 splice sites.19
Previously, ribosomal protein S6 has been described as a
regulator of translational capacity and differential mRNA
expression in yeast,20 as well as playing a nuclear role, as
evidenced by the reported effect on the size of the yeast
cells during cell growth.21 Chiocchetti et al22 showed that
rpS6 are potent regulators of yeast replicative aging and
that rpS18 is a moderate, but significant modulator of yeast
replicative life span, possibly by quantitatively and quali-
tatively modulating the synthesis of proteins operative in
the aging process. Ribosomal protein S5 belongs to a family
of ribosomal proteins that includes bacterial rpS7 and rpS5/
rpS7, and forms part of the exit site on the small ribosomal
subunit.23,24 In Saccharomyces cerevisiae, rpS5 is repre-
sented by a single gene copy and is essential for cell
viability.25 Histone H4 is also upregulated and responsible
for proper nucleosome assembly. A study of Saccharomyces
cerevisiae mutants with histone alanine substitution near
the C terminus of H4 led to a unique phenotype.26 The
mutants grew slowly and also lost chromosomes at a high
rate, probably because their kinetochores were not
assembled properly.
In short, the above findings suggest that increasing the
translational capacity, ensuring proper nucleosome as-
sembly, and upregulating other ribosome-associatedrelative and absolute quantitation-based comparative proteomic
nmental genotype 1 strains, Journal of Microbiology, Immunology
Table 2 Functional classification of the differentially expressed proteins identified by isobaric tag for relative and absolute
quantitation in the cluster of orthologous groups mapping; the upregulated and downregulated proteins were for the clinical
isolates (genotype 2) of Prototheca zopfii. compared to the environmental isolates (genotype 1).
Accession No. Protein name Upregulated Downregulated
Translation, ribosomal structure, & biogenesis
A0A087S9N3 40S ribosomal protein S23-2 [
A0A087SN17 DEAD-box ATP-dependent RNA helicase 36 [
E1Z5J4 Cytoplasmic ribosomal protein S13 [
E1ZDD4 40S ribosomal protein S6 [
A0A087SIA2 40S ribosomal protein S18 [
E1ZQY4 40S ribosomal protein S5 [
A0A087SE71 Elongation factor Tu Y
Chromatin structure & dynamics
E1ZFV0 Histone H4 [
Posttranslational modification, protein turnover, & chaperones
A0A087SK35 Prohibitin-1 Y
Energy production & conversion
A0A087SC94 Malate dehydrogenase, glyoxysomal Y
A0A087SS91 Aconitate hydratase, mitochondrial Y
E1Z494 Formin-like protein Y
A0A087SIB1 NADH dehydrogenase (ubiquinone)
iron-sulfur protein 8-A, mitochondrial
Y
A0A087SHT7 Methylmalonate-semialdehyde
dehydrogenase (acylating), mitochondrial
Y
Carbohydrate transport & metabolism
A0A087SCD4 Reversed GDP-mannose 3,5-epimerase 2 Y
A0A087SKC3 Phosphoglucomutase, chloroplastic Y
Nucleotide transport & metabolism
A0A087ST52 CTP synthase [
A0A087SC60 Adenylate kinase B Y
Amino acid transport & metabolism
A0A087SDQ9 Breast cancer type 2 susceptibility protein-like protein [
Lipid transport & metabolism
A0A087SGS4 Succinyl-CoA:3-ketoacid-coenzyme A transferase [
Inorganic ion transport & metabolism
A0A087SDZ5 Plasma membrane ATPase Y
Defense mechanisms
A0A087SKD7 ATP-binding cassette sub-family B member 9 Y
6 Y.-z. Liu et al.
+ MODELactivities, may be important in disease pathogenesis or
adaptation in the host tissue for the clinical isolate P. zopfii
(genotype 2).
Most of the downregulated proteins, including plasma
membrane ATPase, aconitate hydratase, NADH dehydro-
genase ironesulfur protein 8-A, ATP-binding cassette
subfamily B member 9, adenylate kinase B,
methylmalonate-semialdehyde dehydrogenase, and GDP-
mannose 3, 5-epimerase 2, are involved in energy pro-
duction and conversion. Among them, the most abundant
downregulated protein for the two replicate pathogenic
isolates was plasma membrane ATPase. According to
Serrano et al,14 yeast plasma membrane ATPase is essen-
tial for growth and has homology with Naþ-, Kþ-, and Ca2þ-
ATPases. In addition, malate dehydrogenase and phos-
phoglucomutase are both associated with carbohydrate
metabolic process. Malate dehydrogenase isoenzymes are
localized in different cellular compartments and fulfill
important functions in intermediary metabolism.27 Simi-
larly, phosphoglucomutase (PGM) is a key enzyme inPlease cite this article in press as: Liu Yuan-zhi, et al., Isobaric tag fo
analysis of human pathogenic Prototheca zopfii genotype 2 and enviro
and Infection (2016), http://dx.doi.org/10.1016/j.jmii.2016.07.003carbohydrate metabolism that is ubiquitous in nature and
highly conserved among species.28 A Saccharomyces cer-
evisiae mutant strain lacking both PGM genes is not viable
when the cells are exposed to galactose as the sole carbon
source. PGM activity is important to maintain intracellular
Ca2þ homeostasis in yeast.29 Based on the above findings,
we hypothesize that pathogenic strains of P. zopfii may
reduce energy production and conversion, as well as
inhibit carbohydrate metabolism, in order to maintain
infection in the human or animal host.
A recent study was conducted by Irrgang et al,8 using
two-dimensional Western blot analyses and matrix-assisted
laser desorption ionization time-of-flight mass spectrom-
etry, to determine immunogenic proteins and potential
virulence factors of P. zopfii genotype 2. Among the iden-
tified immunodominant proteins, ATPase and malate de-
hydrogenase, which were differentially expressed proteins
in the current study, were hypothesized to represent anti-
gens specific for genotype 2 of P. zopfii. Taken together,
these findings suggest that, among the identifiedr relative and absolute quantitation-based comparative proteomic
nmental genotype 1 strains, Journal of Microbiology, Immunology
Figure 2. Gene ontology classification of the identified proteins as determined for (A) biological process, (B) molecular function,
and (C) cellular component.
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+ MODELdifferential expressed proteins, some can be considered as
potential virulence factors (e.g., ATPase and malate de-
hydrogenase). In another study by Murugaiyan et al,3 which
used two-dimensional fluorescence difference gel electro-
phoresis coupled with matrix-assisted laser desorption
ionization time-of-flight mass spectrometry to identify the
protein expression level difference between the pathogenic
and nonpathogenic strains of P. zopfii, a total of 782 pro-
teins were observed, among which 63 and 44 proteins were
identified to be overexpressed in genotypes 1 and 2,
respectively. According to COG analysis results of Mur-
ugaiyan et al,3 the identified downregulated proteins forPlease cite this article in press as: Liu Yuan-zhi, et al., Isobaric tag for
analysis of human pathogenic Prototheca zopfii genotype 2 and enviro
and Infection (2016), http://dx.doi.org/10.1016/j.jmii.2016.07.003genotype 2 displayed decreased activity in energy produc-
tion and conversion, and carbohydrate transport and
metabolism, which is in agreement with the present study.
In the aforementioned study, the upregulated proteins
were distributed in the category of post-translational
modification, whilst in our study the largest proportion of
the upregulated expressed proteins was related to the
translation, ribosomal structure, and biogenesis. The
different results may be due to different sources of geno-
type 2 strains, this study was from human granulomatous
lymphadenitis, while Murugaiyan et al’s3 study was from
cows with bovine mastitis. Two-dimensional fluorescencerelative and absolute quantitation-based comparative proteomic
nmental genotype 1 strains, Journal of Microbiology, Immunology
Figure 3. Kyoto Encyclopedia of Genes and Genomes Gene (KEGG) pathway analysis. (A) KEGG map of oxidative phosphorylation;
(B) KEGG distribution of identified differentially expressed proteins.
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+ MODELdifference gel electrophoresis and iTRAQ are two different
proteomic quantitative methods, and iTRAQ as an emerging
technology might be more sensitive and accurate while is
more susceptible to errors in precursor ion isolation,30 and
the different databases searcheddthe aforementioned
study used NCBInr and SwissProt databases while the pre-
sent study searched the Uniprot databased may also
contribute to the differences in results and conclusion.
This study has some limitations. Prototheca zopfii ge-
notypes exhibit growth differences when cultured at
different temperatures, including 37C. As such, culturing
genotype 2, an environmental isolate, at 37C may have
induced expression of stress related proteins. However,
environmental Prototheca species have been known to
colonize the human skin and other human parts and sys-
tems, and growth is optimized between 25C and
37C.31e33 Furthermore, our study aimed to compare the
two strains in conditions mimicking the human body
temperature.
In conclusion, we present the first report of iTRAQ-LC/
MS/MS for different pathogenic isolates of P. zopfii. Our
data provide evidence for protein expression differences
between the clinical and environmental isolates of P.
zopfii. The results of our study indicate that P. zopfii ge-
notype 2 differs from genotype 1 in suppressed energy
production and conversion, carbohydrate transport and
metabolism, and in enhanced translation, ribosomal
structure, and biogenesis. Further studies at the protein
level will provide valuable information on the pathogenic
mechanism of P. zopfii genotype 2 infections. Future
studies targeting protein expression by mimicking the
microenvironment could unravel the mechanism and
pathways in the pathogenesis of infections caused by P.
zopfii genotype 2.Conflicts of interest
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